About this Research Topic
Coronavirus (SARS-CoV-2 or COVID) has had an international impact on a significant number of patients worldwide, and is known to adversely affect patients with Diabetes Mellitus. During the pandemic, healthcare has transformed and had to adjust the management of patients with Diabetes Mellitus in several different arenas: as a health system, in the inpatient setting, and in the outpatient setting. These fundamental advances represent in the general approach to care for patients with diabetes, and we therefore call for novel information on Diabetes management during the COVID pandemic.
The goal of this Research Topic collection is to highlight both groundbreaking and fundamental changes in the way Diabetes Mellitus is managed during the COVID pandemic. It will be focusing on therapeutic advancements, therapeutic efficacy, telehealth strategies, health system changes, and quality improvement for improving the care for patients with Diabetes during COVID.
Below are some potential themes that would be of interest:
1) Inpatient glycemic management & diabetes mellitus during the COVID pandemic (including topics on remote management).
2) New considerations for antidiabetic agents for diabetes mellitus during the COVID pandemic.
3) Health systems approach and/or Telehealth approach to diabetes care during the COVID pandemic.
4) New-onset of diabetes mellitus with COVID-19: pathophysiology.
5) International lessons learned from COVID-19 and diabetes management.
6) Strategic approaches to management of obesity during COVID-19 outbreak.
Disclosure: Dr. Zimmerman receives research support from Novo, Bayer.
Keywords: COVID, Diabetes, Inpatient, Outpatient, Management, SARS, Endocrinology
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.